KYMR
Price
$48.77
Change
+$1.49 (+3.15%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
3.38B
44 days until earnings call
ORIC
Price
$10.90
Change
+$0.19 (+1.77%)
Updated
Sep 16, 04:59 PM (EDT)
Capitalization
1.04B
55 days until earnings call
Interact to see
Advertisement

KYMR vs ORIC

Header iconKYMR vs ORIC Comparison
Open Charts KYMR vs ORICBanner chart's image
Kymera Therapeutics
Price$48.77
Change+$1.49 (+3.15%)
Volume$33.05K
Capitalization3.38B
Oric Pharmaceuticals
Price$10.90
Change+$0.19 (+1.77%)
Volume$33.85K
Capitalization1.04B
KYMR vs ORIC Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. ORIC commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a StrongBuy and ORIC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (KYMR: $47.28 vs. ORIC: $10.71)
Brand notoriety: KYMR and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 112% vs. ORIC: 120%
Market capitalization -- KYMR: $3.38B vs. ORIC: $1.04B
KYMR [@Biotechnology] is valued at $3.38B. ORIC’s [@Biotechnology] market capitalization is $1.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.82B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileORIC’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • ORIC’s FA Score: 1 green, 4 red.
According to our system of comparison, ORIC is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 7 TA indicator(s) are bullish while ORIC’s TA Score has 7 bullish TA indicator(s).

  • KYMR’s TA Score: 7 bullish, 3 bearish.
  • ORIC’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, both KYMR and ORIC are a good buy in the short-term.

Price Growth

KYMR (@Biotechnology) experienced а +9.29% price change this week, while ORIC (@Biotechnology) price change was +2.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.28%. For the same industry, the average monthly price growth was +6.89%, and the average quarterly price growth was +33.83%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

ORIC is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+3.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.38B) has a higher market cap than ORIC($1.04B). ORIC YTD gains are higher at: 32.714 vs. KYMR (17.524). ORIC has higher annual earnings (EBITDA): -148.48M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. ORIC (283M). ORIC has less debt than KYMR: ORIC (3.27M) vs KYMR (85.7M). KYMR has higher revenues than ORIC: KYMR (44.7M) vs ORIC (0).
KYMRORICKYMR / ORIC
Capitalization3.38B1.04B325%
EBITDA-267.03M-148.48M180%
Gain YTD17.52432.71454%
P/E RatioN/AN/A-
Revenue44.7M0-
Total Cash665M283M235%
Total Debt85.7M3.27M2,618%
TECHNICAL ANALYSIS
Technical Analysis
KYMRORIC
RSI
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 2 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGIBX41.44N/A
N/A
MFS International Intrinsic Value B
BRSSX15.30N/A
N/A
MFS Blended Research Small Cap Eq R2
GCFSX19.93N/A
N/A
Gabelli Global Financial Services C
TAGHX34.79N/A
N/A
Transamerica US Growth R6
MMPDX34.79-0.13
-0.37%
NYLI WMC Value Class R6

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.62%
NRIX - KYMR
67%
Closely correlated
-4.09%
VERA - KYMR
59%
Loosely correlated
+1.98%
CGON - KYMR
54%
Loosely correlated
+3.78%
RGNX - KYMR
52%
Loosely correlated
-1.20%
LYRA - KYMR
52%
Loosely correlated
-0.16%
More

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with ERAS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
-0.65%
ERAS - ORIC
46%
Loosely correlated
+2.56%
ROIV - ORIC
46%
Loosely correlated
-0.92%
KYMR - ORIC
46%
Loosely correlated
+0.62%
ETNB - ORIC
45%
Loosely correlated
-0.62%
ACLX - ORIC
44%
Loosely correlated
-1.30%
More